Recent Company News

• 06:35 PM ET Apr 10, 2026
  

  Follow-up: Hemab Therapeutics files for Nasdaq IPO of indeterminate size

• 04:24 AM ET Feb 27, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 03:57 AM ET Mar 25, 2026
  

  StreetAccount Summary - European pre-market trading update

• 03:09 AM ET Mar 25, 2026
  

  European macro headlines:

• 05:30 PM ET Mar 24, 2026
  

  Grifols preparing IPO of US Biopharma business (€8.84, 0.00)

• 08:37 AM ET Mar 17, 2026
  

  Grifols shares proof-of-concept data from Chronos-PD program (€9.32, 0.00)

• 03:24 AM ET Mar 16, 2026
  

  Grifols doubles RCF to $2B (€9.22, 0.00)

• 01:38 AM ET Mar 10, 2026
  

  Grifols downgraded to equal-weight from overweight at Morgan Stanley (€9.92, 0.00)

• 08:20 AM ET Mar 05, 2026
  

  Trump's trade embargo threat against Spain legally possible but practically toothless: